Indeed, reports indicate a decrease in the expression of WT1 and nephrin in patients with minimal change disease (MCD) and focal segmental glomerulosclerosis (FSGS), suggesting a correlation between the expression of WT1 and nephrin in podocyte function in nephrotic syndrome [22]. Here, NPHS1 is linked to focal segmental glomerulosclerosis.